Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Concerto HealthAI (company)

Concerto HealthAI (company)

Concerto Health AI is a Boston-based company which provides data and AI-driven solutions to life science researchers and healthcare providers.

Concerto HealthAI is a multifaceted oncology research platform in Massachusetts that focuses on designing and delivering care based oncology research and data analytics. Founded 2017 in Boston, Massachusetts, United States, Concerto HealthAI specializes in oncology health outcomes and clinical trial efficiency research, using custom patient surveys to help pharmaceutical companies evaluate currently approved treatments and develop new treatments. This platform further enables project teams, medical experts and outcome scientists to design and deliver projects generating real-world evidence and insight. Concerto HealthAI is a real-world data, AI technology, and real-world evidence services for precision oncology. The company engineers integrated data and technology solutions that help achieve outcomes for patients.

Timeline

July 1, 2020
Series B - Concerto
2017
Founded

Funding rounds

Patents

Further Resources

Title
Author
Link
Type
Date

Artificial Intelligence Relies Upon a Clean Data Pipeline - Concerto HealthAI

Web

News

Title
Author
Date
Publisher
Description
Mark Terry
November 17, 2020
BioSpace
There are many examples of how biopharma is leveraging AI and forging partnerships with companies focused on AI for drug development and clinical trials. There have been a few recent AI-based partnerships as well.

References

Golden logo
By using this site, you agree to our Terms & Conditions.